Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6100340 | Journal of Crohn's and Colitis | 2011 | 4 Pages |
Abstract
Our current knowledge is not sufficient to rule out an increased risk of lymphoma associated with biologics, or allow definitive conclusions to be drawn about the association of infliximab and lymphoma. However, this case and others direct the attention to that both higher index of suspicion and closer follow up are required if patients are maintained on long-term infliximab together with other immunosuppressive therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Maria Rojas-Feria, Mohammed Eslam, Manuel Castro-Fernández, Pedro Guerrero, Jose-Luis Larraona-Moreno, Manuel Romero-Gómez,